These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11920645)

  • 1. Monoclonal and polyclonal humoral immune response to EC HER-2/NEU peptides with low similarity to the host's proteome.
    Mittelman A; Lucchese A; Sinha AA; Kanduc D
    Int J Cancer; 2002 Apr; 98(5):741-7. PubMed ID: 11920645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of MHC II affinity and molecular mimicry in defining anti-HER-2/neu MAb-3 linear peptide epitope.
    Lucchese A; Stevanovic S; Sinha AA; Mittelman A; Kanduc D
    Peptides; 2003 Feb; 24(2):193-7. PubMed ID: 12668202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neu.
    Jasinska J; Wagner S; Radauer C; Sedivy R; Brodowicz T; Wiltschke C; Breiteneder H; Pehamberger H; Scheiner O; Wiedermann U; Zielinski CC
    Int J Cancer; 2003 Dec; 107(6):976-83. PubMed ID: 14601058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individuation of monoclonal anti-HPV16 E7 antibody linear peptide epitope by computational biology.
    Kanduc D; Lucchese A; Mittelman A
    Peptides; 2001 Dec; 22(12):1981-5. PubMed ID: 11786180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of HER2/ neu-derived peptides capable of inducing both cellular and humoral immune responses in HLA-A24 positive breast cancer patients.
    Azuma K; Shichijo S; Shomura H; Matsueda S; Fujii T; Itoh K
    Breast Cancer Res Treat; 2004 Jul; 86(1):19-29. PubMed ID: 15218358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity.
    Tiwari R; Geliebter J; Lucchese A; Mittelman A; Kanduc D
    Peptides; 2004 Nov; 25(11):1865-71. PubMed ID: 15501517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu.
    Riemer AB; Klinger M; Wagner S; Bernhaus A; Mazzucchelli L; Pehamberger H; Scheiner O; Zielinski CC; Jensen-Jarolim E
    J Immunol; 2004 Jul; 173(1):394-401. PubMed ID: 15210798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both the epitope specificity and isotype are important in the antitumor effect of monoclonal antibodies against Her-2/neu antigen.
    Kim KM; Shin EY; Moon JH; Heo TH; Lee JY; Chung Y; Lee YJ; Cho HM; Shin SU; Kang CY
    Int J Cancer; 2002 Dec; 102(4):428-34. PubMed ID: 12402315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
    Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee HG; Kanz L; Brugger W
    Cancer Res; 1998 Feb; 58(4):732-6. PubMed ID: 9485028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine monoclonal anti-idiotypic antibody as a surrogate antigen for human Her-2/neu.
    Baral R; Sherrat A; Das R; Foon KA; Bhattacharya-Chatterjee M
    Int J Cancer; 2001 Apr; 92(1):88-95. PubMed ID: 11279611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope.
    Kanduc D; Fanizzi FP; Lucchese G; Stevanovic S; Sinha AA; Mittelman A
    Peptides; 2004 Feb; 25(2):243-50. PubMed ID: 15063005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of new HER2 peptide vaccination based on B cell epitope.
    Miyako H; Kametani Y; Katano I; Ito R; Tsuda B; Furukawa A; Saito Y; Ishikawa D; Ogino K; Sasaki S; Imai K; Habu S; Makuuchi H; Tokuda Y
    Anticancer Res; 2011 Oct; 31(10):3361-8. PubMed ID: 21965747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice.
    Wagner S; Jasinska J; Breiteneder H; Kundi M; Pehamberger H; Scheiner O; Zielinski CC; Wiedermann U
    Breast Cancer Res Treat; 2007 Nov; 106(1):29-38. PubMed ID: 17203384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo.
    Spiridon CI; Ghetie MA; Uhr J; Marches R; Li JL; Shen GL; Vitetta ES
    Clin Cancer Res; 2002 Jun; 8(6):1720-30. PubMed ID: 12060609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel engineered trastuzumab conformational epitopes demonstrate in vitro and in vivo antitumor properties against HER-2/neu.
    Garrett JT; Rawale S; Allen SD; Phillips G; Forni G; Morris JC; Kaumaya PT
    J Immunol; 2007 Jun; 178(11):7120-31. PubMed ID: 17513761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine.
    Disis ML; Grabstein KH; Sleath PR; Cheever MA
    Clin Cancer Res; 1999 Jun; 5(6):1289-97. PubMed ID: 10389911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel immunogenic HLA-A*0201-binding epitope of HER-2/neu with potent antitumor properties.
    Gritzapis AD; Voutsas IF; Lekka E; Tsavaris N; Missitzis I; Sotiropoulou P; Perez S; Papamichail M; Baxevanis CN
    J Immunol; 2008 Jul; 181(1):146-54. PubMed ID: 18566379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of epitope regions recognized by tumor inhibitory and stimulatory anti-ErbB-2 monoclonal antibodies: implications for vaccine design.
    Yip YL; Smith G; Koch J; Dübel S; Ward RL
    J Immunol; 2001 Apr; 166(8):5271-8. PubMed ID: 11290813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p185 HER2/neu epitope mapping with murine monoclonal antibodies.
    Centis F; Tagliabue E; Uppugunduri S; Pellegrini R; Martignone S; Mastroianni A; Ménard S; Colnaghi MI
    Hybridoma; 1992 Jun; 11(3):267-76. PubMed ID: 1379973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Immunogenicity Against a Her2/neu-Derived Peptide by Employment of a Pan HLA DR-Binding Epitope and CpG in a BALB/c Mice Model.
    Tahaghoghi-Hajghorbani S; Tavakkol-Afshari J; Jaafari MR; Ghaffari-Nazari H; Masoumi E; Jalali SA
    Anticancer Agents Med Chem; 2017; 17(6):851-858. PubMed ID: 27924731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.